Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors Mechelen, Belgium; October 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new in vitro pharmacological data from its selective TYK2 inhibitor, GLPG3667, currently in two Phase 3-enabling studies in dermatomyositis (DM) and systemic lupus erythematosus (SLE), at the American College of Rheumatology (ACR) Convergence 2025, taking place in Chicago, IL, October 24-29, 2025. The data show that the in vitro pharmacological ...
Galapagos presenteert in vitro-gegevens tijdens ACR Convergence 2025 die wijzen op differentiatie van GLPG3667 ten opzichte van andere TYK2-remmers Mechelen, België; 23 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag aangekondigd dat het nieuwe in vitro farmacologische gegevens zal presenteren van zijn selectieve TYK2-remmer, GLPG3667, die momenteel in twee fase 3-bepalende studies wordt onderzocht bij dermatomyositis (DM) en systemische lupus erythematodes (SLE), op het American College of Rheumatology (ACR) Convergence 2025, dat plaatsvindt in Chicago, Illino...
UPDATE ON FIXED INCOME INVESTOR MEETINGS Press release Antwerp, Oct. 23, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMB.TECH”) references the stock exchange release dated 20 October 2025 regarding fixed income investor meetings. Following engagement with potential investors, CMB.TECH has decided not to proceed with the issue of a senior unsecured bond. The indicative terms offered under the current market conditions were less favourable compared to the other funding sources available to the Company. For further informat...
Galapagos announced its intention to wind down its cell therapy business following a strategic review. This follows a previous announcement of non-binding offers, subject to financing, where previous CEO Paul Stoffels emerged as one of the bidders for the business. This decision suggests external financing for the project has not been obtained, and we believe the decision to wind down the cell therapy business creates clarity and allows Galapagos to move forward with its new plans of building a ...
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos Mechelen, Belgium; October 21, 2025, 07:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced its intention to wind down its cell therapy business and pursue new transformational business development transactions with its available cash resources. The in...
Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf Deze intentie volgt na een uitgebreid strategisch evaluatieproces en zou de meest optimale manier zijn om kapitaal toe te wijzen ter ondersteuning van een sterkere en duurzame toekomst voor Galapagos Mechelen, België; 21 oktober 2025, 07:30 CET; gereglementeerde informatie – voorwetenschap – Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag de intentie aan om haar celtherapieactiviteiten af te bouwen en met zijn beschikbare kasmiddelen nieuwe baanbre...
This morning CMB.TECH issued an update which went unnoticed due to technical issues. We presume the release has to do with the ongoing fixed income investor meetings to refinance (half of) the $1.4bn bridge loan taken out to acquire the stake in Golden Ocean. The update was limited to the publication of TCE rates and confirmed the rumoured sale of the VLCC Dalma (°2007) which resulted in a handsome $27m capital gain. The attractive rate fixtures in the 4Q25 more than make up for the shortfall in...
PRESS RELEASE: CMB.TECH NV announces fixed income investor meetings Antwerp, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMB.TECH”) has mandated Danske Bank, DNB Carnegie, Nordea Bank and Pareto Securities to arrange a series of fixed income investor meetings commencing today, October 20, 2025. Following the investor meetings a USD denominated five-year senior unsecured bond issue may follow, subject to inter alia market conditions. The proceeds from the potential bond issue will be used for general corporate purp...
PRESS RELEASE: CMB.TECH trading update Antwerp, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMB.TECH”) provides a market update. During Q3 and Q4 to date, CMB.TECH has continued its fleet rejuvenation strategy with the sale of two older vessels and the delivery of five newbuild vessels. Fleet update Deliveries CMB.TECH took delivery of 5 newbuilding vessels in Q3 and Q4 to date: Eco-Newcastlemaxes: Mineral Slovensko and Mineral Slovenija Chemical tanker: Bochem Santos CTV: Windcat 58 ...
On Friday afternoon, news broke—confirming earlier speculation on Thursday—that the IMO has postponed the vote on adopting the Net-Zero Framework by one year. The delay followed intense lobbying against the measures, led by the US and Saudi Arabia. In Friday's vote, 57 countries supported the delay (including the US, China, Panama, and Liberia), while 49 opposed (including most EU member states). The path forward for shipping emissions regulation remains unclear, with renegotiation potentially r...
Galapagos Announces Appointment of Fred Blakeslee as General Counsel Mechelen, Belgium; October 16, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Mr. Fred Blakeslee as Executive Vice President and General Counsel effective October 16, 2025. Blakeslee is succeeding Ms. Valeria Cnossen, who will leave the Company after a short transition period. “We are very pleased to welcome Fred to the executive team,” said Henry Gosebruch, CEO of Galapagos. “He brings a unique combination of top-tier legal expertise, global business transaction experience, an...
Galapagos kondigt benoeming aan van Fred Blakeslee als General Counsel Mechelen, België; 16 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag de benoeming bekendgemaakt van de heer Fred Blakeslee tot Executive Vice President en General Counsel met ingang van 16 oktober 2025. Blakeslee volgt mevrouw Valeria Cnossen op, die het bedrijf zal verlaten na een korte transitieperiode. “We zijn erg blij Fred te mogen verwelkomen in het managementteam,” aldus Henry Gosebruch, CEO van Galapagos. “Hij combineert juridische expertise op topniveau met ruime ervaring in inter...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.